| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |